NICE to back new Alzheimer's drugs

Draft guidance from NICE has supported the use of new drug memantine for the first time.

In the guidance, NICE advises that memantine, an NMDA-receptor antagonist, should be offered to patients with moderate Alzheimer's who are intolerant of, or have a contraindication to, AChE inhibitors. NICE said the drug should also be offered to patients with severe disease.

Previously, NICE had not recommended memantine on cost effectiveness grounds, but has reversed its decision in light of new efficacy data.

NICE also extended its recommendation for the use of three acetylcholinesterase (AChE) inhibitors – donepezil, galantamine and rivastigmine – to include mild, as well as moderate, disease.

NICE chief executive Sir Andrew Dillon said: ‘Our increased confidence in the benefits and costs associated with the use of the three drugs for treating mild and moderate stages of the disease has enabled us to make a positive recommendation for their use in mild disease.’

A consultation on the guidance will run until 28 October.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medico-legal: Intimate examinations and chaperones during COVID-19

Medico-legal: Intimate examinations and chaperones during COVID-19

Remote consultations are likely to be a key part of general practice for months to...

NHS England promises detail on additional flu funding ‘by end of August’

NHS England promises detail on additional flu funding ‘by end of August’

GPs may have to wait until the end of August to find out details of any additional...

Why 63% of GPs expect to do more home-working after COVID-19

Why 63% of GPs expect to do more home-working after COVID-19

Working from home was one of the key issues raised in GPonline's survey of more than...

Lack of support during the menopause leading female doctors to quit

Lack of support during the menopause leading female doctors to quit

A lack of support during the menopause has led some female doctors to consider reducing...

One in three single-handed GPs at high-risk from COVID-19

One in three single-handed GPs at high-risk from COVID-19

A third of single-handed GPs are at high-risk from COVID-19, which could potentially...

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Dr Mark Spencer explains how the COVID-19 pandemic helped his primary care network...